AVIR — Atea Pharmaceuticals, Inc. stock price, charts and financials

QT57Atea Pharmaceuticals, Inc.

Atea Pharmaceuticals, Inc. (NASDAQ: AVIR) is a Healthcare company in the Biotechnology industry. QuoTrend tracks its price, financials, earnings, analyst ratings and insider trades.

Latest market price
4.70
+0.09+1.95%
OverviewShort InterestFilings
AVIRQT57Atea Pharmaceuticals, Inc.·NASDAQ
4.70+1.95%

Latest SEC Filings

Form category
Filing Date ▾FormDescriptionFilingDocument
Jun 23, 20264Statement of changes in beneficial ownership
Jun 23, 20264Statement of changes in beneficial ownership
Jun 23, 20264Statement of changes in beneficial ownership
Jun 23, 20264Statement of changes in beneficial ownership
Jun 23, 20264Statement of changes in beneficial ownership
Jun 23, 20264Statement of changes in beneficial ownership
Jun 23, 20264Statement of changes in beneficial ownership
Jun 23, 20264Statement of changes in beneficial ownership
Jun 22, 20268-KCurrent report
May 21, 20264/AStatement of changes in beneficial ownership (amended)
May 20, 20264Statement of changes in beneficial ownership
May 12, 202610-QQuarterly report
May 12, 20268-KCurrent report
May 06, 2026SC 13G/ABeneficial ownership statement (passive, amended)
Apr 27, 2026DEFA14AAdditional proxy soliciting materials
Apr 27, 2026DEF 14ADefinitive proxy statement
Mar 26, 2026SC 13G/ABeneficial ownership statement (passive, amended)
Mar 13, 20264Statement of changes in beneficial ownership
Mar 05, 202610-KAnnual report
Mar 05, 20268-KCurrent report
Feb 09, 2026SC 13GBeneficial ownership statement (passive)
Feb 03, 20264Statement of changes in beneficial ownership
Feb 03, 20264Statement of changes in beneficial ownership
Feb 03, 20264Statement of changes in beneficial ownership
Feb 03, 20264Statement of changes in beneficial ownership
#1 / 25 of 226
Page
▼
/ 10